Cargando…
A retrospective study of end-stage kidney disease patients on maintenance hemodialysis with renal osteodystrophy-associated fragility fractures
BACKGROUND: Nephropathy associated metabolic disorder induces high incidence of fragility fracture in end-stage renal disease (ESRD) patients. As the risk factors and prognosis of fragility fracture in ESRD patients are unclear, more research is needed. This study aimed to evaluate various risk fact...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802139/ https://www.ncbi.nlm.nih.gov/pubmed/33430788 http://dx.doi.org/10.1186/s12882-020-02224-7 |
_version_ | 1783635710261067776 |
---|---|
author | Xie, Lihua Hu, Xuantao Li, Wenzhao Ouyang, Zhengxiao |
author_facet | Xie, Lihua Hu, Xuantao Li, Wenzhao Ouyang, Zhengxiao |
author_sort | Xie, Lihua |
collection | PubMed |
description | BACKGROUND: Nephropathy associated metabolic disorder induces high incidence of fragility fracture in end-stage renal disease (ESRD) patients. As the risk factors and prognosis of fragility fracture in ESRD patients are unclear, more research is needed. This study aimed to evaluate various risk factors for ESRD-related fragility fractures, explore factors affecting the prognosis of patients with such fractures, and provide information for prevention and treatment of renal osteopathy to improve the prognosis of patients. METHODS: In this retrospective case-control study, the case notes of 521 ESRD patients who received maintenance dialysis for at least 3 months were examined. Finally, 44 patients diagnosed with fragility fractures were assigned to the fragility fracture (FF) group and 192 patients were included in the control group (CG). Demographic information, underlying diseases, nutritional, bone metabolism, and renal function parameters, along with the number and causes of any deaths, were recorded for multiple statistical analysis. RESULTS: The FF group had increased incidences of essential hypertension and diabetes mellitus and higher serum calcium, corrected calcium, alkaline phosphatase, and hemoglobin levels. Immunoreactive parathyroid hormone (iPTH), total cholesterol (TC), and low density lipoprotein (LDL) levels were higher in the CG. Multivariate Cox regression analysis revealed that fragility fracture was an independent risk factor for all-cause mortality in ESRD patients (P < .001, RR: 4.877, 95% CI: 2.367–10.013). CONCLUSIONS: Essential hypertension and diabetes, high serum calcium and alkaline phosphatase levels, and reduced iPTH levels were risk factors for fragility fracture in ESRD patients. Maintaining iPTH and serum TC levels may protect against fragility fractures in them. Fragility fractures may yield poor prognosis and shorter lifespan. The presence of fragility fracture was an independent predictor of all-cause death in ESRD patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12882-020-02224-7. |
format | Online Article Text |
id | pubmed-7802139 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-78021392021-01-12 A retrospective study of end-stage kidney disease patients on maintenance hemodialysis with renal osteodystrophy-associated fragility fractures Xie, Lihua Hu, Xuantao Li, Wenzhao Ouyang, Zhengxiao BMC Nephrol Research Article BACKGROUND: Nephropathy associated metabolic disorder induces high incidence of fragility fracture in end-stage renal disease (ESRD) patients. As the risk factors and prognosis of fragility fracture in ESRD patients are unclear, more research is needed. This study aimed to evaluate various risk factors for ESRD-related fragility fractures, explore factors affecting the prognosis of patients with such fractures, and provide information for prevention and treatment of renal osteopathy to improve the prognosis of patients. METHODS: In this retrospective case-control study, the case notes of 521 ESRD patients who received maintenance dialysis for at least 3 months were examined. Finally, 44 patients diagnosed with fragility fractures were assigned to the fragility fracture (FF) group and 192 patients were included in the control group (CG). Demographic information, underlying diseases, nutritional, bone metabolism, and renal function parameters, along with the number and causes of any deaths, were recorded for multiple statistical analysis. RESULTS: The FF group had increased incidences of essential hypertension and diabetes mellitus and higher serum calcium, corrected calcium, alkaline phosphatase, and hemoglobin levels. Immunoreactive parathyroid hormone (iPTH), total cholesterol (TC), and low density lipoprotein (LDL) levels were higher in the CG. Multivariate Cox regression analysis revealed that fragility fracture was an independent risk factor for all-cause mortality in ESRD patients (P < .001, RR: 4.877, 95% CI: 2.367–10.013). CONCLUSIONS: Essential hypertension and diabetes, high serum calcium and alkaline phosphatase levels, and reduced iPTH levels were risk factors for fragility fracture in ESRD patients. Maintaining iPTH and serum TC levels may protect against fragility fractures in them. Fragility fractures may yield poor prognosis and shorter lifespan. The presence of fragility fracture was an independent predictor of all-cause death in ESRD patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12882-020-02224-7. BioMed Central 2021-01-11 /pmc/articles/PMC7802139/ /pubmed/33430788 http://dx.doi.org/10.1186/s12882-020-02224-7 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Xie, Lihua Hu, Xuantao Li, Wenzhao Ouyang, Zhengxiao A retrospective study of end-stage kidney disease patients on maintenance hemodialysis with renal osteodystrophy-associated fragility fractures |
title | A retrospective study of end-stage kidney disease patients on maintenance hemodialysis with renal osteodystrophy-associated fragility fractures |
title_full | A retrospective study of end-stage kidney disease patients on maintenance hemodialysis with renal osteodystrophy-associated fragility fractures |
title_fullStr | A retrospective study of end-stage kidney disease patients on maintenance hemodialysis with renal osteodystrophy-associated fragility fractures |
title_full_unstemmed | A retrospective study of end-stage kidney disease patients on maintenance hemodialysis with renal osteodystrophy-associated fragility fractures |
title_short | A retrospective study of end-stage kidney disease patients on maintenance hemodialysis with renal osteodystrophy-associated fragility fractures |
title_sort | retrospective study of end-stage kidney disease patients on maintenance hemodialysis with renal osteodystrophy-associated fragility fractures |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802139/ https://www.ncbi.nlm.nih.gov/pubmed/33430788 http://dx.doi.org/10.1186/s12882-020-02224-7 |
work_keys_str_mv | AT xielihua aretrospectivestudyofendstagekidneydiseasepatientsonmaintenancehemodialysiswithrenalosteodystrophyassociatedfragilityfractures AT huxuantao aretrospectivestudyofendstagekidneydiseasepatientsonmaintenancehemodialysiswithrenalosteodystrophyassociatedfragilityfractures AT liwenzhao aretrospectivestudyofendstagekidneydiseasepatientsonmaintenancehemodialysiswithrenalosteodystrophyassociatedfragilityfractures AT ouyangzhengxiao aretrospectivestudyofendstagekidneydiseasepatientsonmaintenancehemodialysiswithrenalosteodystrophyassociatedfragilityfractures AT xielihua retrospectivestudyofendstagekidneydiseasepatientsonmaintenancehemodialysiswithrenalosteodystrophyassociatedfragilityfractures AT huxuantao retrospectivestudyofendstagekidneydiseasepatientsonmaintenancehemodialysiswithrenalosteodystrophyassociatedfragilityfractures AT liwenzhao retrospectivestudyofendstagekidneydiseasepatientsonmaintenancehemodialysiswithrenalosteodystrophyassociatedfragilityfractures AT ouyangzhengxiao retrospectivestudyofendstagekidneydiseasepatientsonmaintenancehemodialysiswithrenalosteodystrophyassociatedfragilityfractures |